468 related articles for article (PubMed ID: 30692991)
41. Empowering dendritic cell cancer vaccination: the role of combinatorial strategies.
Galati D; Zanotta S
Cytotherapy; 2018 Nov; 20(11):1309-1323. PubMed ID: 30360963
[TBL] [Abstract][Full Text] [Related]
42. Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
Pierce S; Geanes ES; Bradley T
Front Cell Infect Microbiol; 2020; 10():231. PubMed ID: 32509600
[TBL] [Abstract][Full Text] [Related]
43. Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors.
Chester C; Marabelle A; Houot R; Kohrt HE
Curr Opin Immunol; 2015 Apr; 33():1-8. PubMed ID: 25576932
[TBL] [Abstract][Full Text] [Related]
44. Targeting tumor-associated immune suppression with selective protein kinase A type I (PKAI) inhibitors may enhance cancer immunotherapy.
Hussain M; Shah Z; Abbas N; Javeed A; Mukhtar MM; Zhang J
Med Hypotheses; 2016 Jan; 86():56-9. PubMed ID: 26804598
[TBL] [Abstract][Full Text] [Related]
45. Radiation and immunotherapy: a synergistic combination.
Kalbasi A; June CH; Haas N; Vapiwala N
J Clin Invest; 2013 Jul; 123(7):2756-63. PubMed ID: 23863633
[TBL] [Abstract][Full Text] [Related]
46. Cancer vaccination at older age.
Gravekamp C
Interdiscip Top Gerontol; 2013; 38():28-37. PubMed ID: 23503513
[TBL] [Abstract][Full Text] [Related]
47. Innate immunity in cutaneous melanoma.
Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
[TBL] [Abstract][Full Text] [Related]
48. Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy.
Park SY; Kim IS
Cancer Lett; 2019 Jun; 452():51-58. PubMed ID: 30910590
[TBL] [Abstract][Full Text] [Related]
49. Adaptive Immunity and the Tumor Microenvironment.
Han ; Lotze
Cancer Treat Res; 2020; 180():111-147. PubMed ID: 32215868
[TBL] [Abstract][Full Text] [Related]
50. Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.
Zhu EF; Gai SA; Opel CF; Kwan BH; Surana R; Mihm MC; Kauke MJ; Moynihan KD; Angelini A; Williams RT; Stephan MT; Kim JS; Yaffe MB; Irvine DJ; Weiner LM; Dranoff G; Wittrup KD
Cancer Cell; 2015 Apr; 27(4):489-501. PubMed ID: 25873172
[TBL] [Abstract][Full Text] [Related]
51. NK cells interactions with dendritic cells shape innate and adaptive immunity.
Brilot F; Strowig T; Munz C
Front Biosci; 2008 May; 13():6443-54. PubMed ID: 18508671
[TBL] [Abstract][Full Text] [Related]
52. Born to Kill: NK Cells Go to War against Cancer.
Wennerberg E; Galluzzi L
Trends Cancer; 2019 Mar; 5(3):143-145. PubMed ID: 30898260
[TBL] [Abstract][Full Text] [Related]
53. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases.
Gardiner CM; Mills KH
Semin Immunol; 2016 Aug; 28(4):343-50. PubMed ID: 26979658
[TBL] [Abstract][Full Text] [Related]
54. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
[TBL] [Abstract][Full Text] [Related]
55. [The role of radiotherapy in the induction of antitumor immune responses].
Multhoff G; Gaipl US; Niedermann G
Strahlenther Onkol; 2012 Nov; 188 Suppl 3():312-5. PubMed ID: 22907580
[No Abstract] [Full Text] [Related]
56. Tricking the balance: NK cells in anti-cancer immunity.
Pahl J; Cerwenka A
Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
[TBL] [Abstract][Full Text] [Related]
57. Innate immune recognition of cancer.
Woo SR; Corrales L; Gajewski TF
Annu Rev Immunol; 2015; 33():445-74. PubMed ID: 25622193
[TBL] [Abstract][Full Text] [Related]
58. Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches.
Gómez V; Mustapha R; Ng K; Ng T
Br J Clin Pharmacol; 2020 Sep; 86(9):1726-1735. PubMed ID: 32388875
[TBL] [Abstract][Full Text] [Related]
59. Long-term treatment with a health product (Squina Diacylglyceryl Ether) enhances innate and adaptive immunity in mice.
Leung HY; Ko KM
J Complement Integr Med; 2012 Nov; 9():. PubMed ID: 23192054
[TBL] [Abstract][Full Text] [Related]
60. Effect of tumor cells and tumor microenvironment on NK-cell function.
Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
